Albany Molecular Reports Q2 Adj. EPS $0.12 on Sales $59.3M; Sees Q3 Adj. EPS $0.08-0.12 on Sales $51-53M, Raises FY13 Adj. EPS Guidance from $0.52-0.65 to $0.54-0.65, Sales from $205-213M to $209-213M